A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation
Ha Won Lee(St. Jude Children's Research Hospital), Christopher DeRenzo(St. Jude Children's Research Hospital)
Cited by 5
Related Papers
CD47 expression is critical for CAR T-cell survival in vivo
|Journal for ImmunoTherapy of Cancer|2023|34
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models
|Clinical Cancer Research|2024|28